JP2019513769A5 - - Google Patents

Download PDF

Info

Publication number
JP2019513769A5
JP2019513769A5 JP2018553392A JP2018553392A JP2019513769A5 JP 2019513769 A5 JP2019513769 A5 JP 2019513769A5 JP 2018553392 A JP2018553392 A JP 2018553392A JP 2018553392 A JP2018553392 A JP 2018553392A JP 2019513769 A5 JP2019513769 A5 JP 2019513769A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
mucosa
strain
composition according
kit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018553392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019513769A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/028133 external-priority patent/WO2017184601A1/en
Publication of JP2019513769A publication Critical patent/JP2019513769A/ja
Publication of JP2019513769A5 publication Critical patent/JP2019513769A5/ja
Pending legal-status Critical Current

Links

JP2018553392A 2016-04-19 2017-04-18 アトピー性皮膚炎を処置するためのグラム陰性種の使用 Pending JP2019513769A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662324762P 2016-04-19 2016-04-19
US62/324,762 2016-04-19
PCT/US2017/028133 WO2017184601A1 (en) 2016-04-19 2017-04-18 Use of gram negative species to treat atopic dermatitis

Publications (2)

Publication Number Publication Date
JP2019513769A JP2019513769A (ja) 2019-05-30
JP2019513769A5 true JP2019513769A5 (cg-RX-API-DMAC7.html) 2020-05-21

Family

ID=58708000

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018553392A Pending JP2019513769A (ja) 2016-04-19 2017-04-18 アトピー性皮膚炎を処置するためのグラム陰性種の使用

Country Status (11)

Country Link
US (8) US10195236B2 (cg-RX-API-DMAC7.html)
EP (2) EP3445330B1 (cg-RX-API-DMAC7.html)
JP (1) JP2019513769A (cg-RX-API-DMAC7.html)
KR (1) KR102340006B1 (cg-RX-API-DMAC7.html)
CN (1) CN109310626A (cg-RX-API-DMAC7.html)
AU (2) AU2017253935B2 (cg-RX-API-DMAC7.html)
CA (1) CA3020863A1 (cg-RX-API-DMAC7.html)
IL (1) IL262455A (cg-RX-API-DMAC7.html)
MX (1) MX2018012719A (cg-RX-API-DMAC7.html)
SG (1) SG11201809100QA (cg-RX-API-DMAC7.html)
WO (1) WO2017184601A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2016003325A (es) * 2013-10-03 2016-07-06 Nitto Denko Corp Composicion de vacuna para mucosa.
CA3016059A1 (en) 2016-03-04 2017-09-08 The Regents Of The University Of California Microbial consortium and uses thereof
EP3445330B1 (en) 2016-04-19 2022-07-06 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of gram negative species to treat atopic dermatitis
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
EP3720458A4 (en) 2017-12-05 2021-12-08 BioPlx, Inc. METHODS AND COMPOSITIONS FOR PREVENTING MICROBIAL INFECTION
AU2019253714A1 (en) 2018-04-10 2020-11-26 Siolta Therapeutics, Inc. Microbial consortia
BR112020021274A2 (pt) * 2018-04-18 2021-04-13 Forte Subsidiary, Inc. Composições para o tratamento de doenças da pele
KR20210013080A (ko) * 2018-05-11 2021-02-03 포르테 서브시디어리, 인크. 피부 병태의 치료를 위한 조성물
EA202190171A1 (ru) * 2018-07-23 2021-06-24 Зэ Юнайтед Стэйтс Оф Америка, Эс Репрезентид Бай Зэ Секретри, Департмент Оф Хэлс Энд Хьюман Сервисез Применение грамотрицательных видов для лечения атопического дерматита
KR102691625B1 (ko) 2022-04-19 2024-08-06 코스맥스 주식회사 세디미니박테리움 락티스 균주 및 그의 피부 상태 개선 용도
KR102691627B1 (ko) 2022-04-19 2024-08-06 코스맥스 주식회사 로제오모나스 뮤코사 균주 및 그의 피부 상태 개선 용도
CN115140846B (zh) * 2022-07-06 2024-06-21 江苏聚庚科技股份有限公司 一种复合处理剂、制备方法及其在净化废水中的应用
CN116139163B (zh) * 2023-03-22 2023-09-05 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种粘液玫瑰单胞菌胞外多糖在制备用于缓解特应性皮炎的药物上的应用

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1019523A (en) 1910-03-14 1912-03-05 Maxmillian E Primbs Ironing-table.
US1020695A (en) 1911-11-17 1912-03-19 Hess Mfg Co Drier.
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3832253A (en) 1973-03-21 1974-08-27 Baxter Laboratories Inc Method of making an inflatable balloon catheter
US4667014A (en) 1983-03-07 1987-05-19 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide analogs of LHRH, useful as LHRH antagonists
US4452775A (en) 1982-12-03 1984-06-05 Syntex (U.S.A.) Inc. Cholesterol matrix delivery system for sustained release of macromolecules
CA1200416A (en) 1983-05-13 1986-02-11 Societe Des Produits Nestle S.A. Food process
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
JPH04167172A (ja) 1990-10-31 1992-06-15 Nec Corp ベクトルプロセッサ
AU692486B2 (en) 1993-10-22 1998-06-11 Smithkline Beecham Corporation Pharmaceutical or veterinary composition comprising mupirocin or a salt thereof in a cream base
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
EP1067956B1 (en) 1998-04-03 2007-03-14 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
WO2003011261A1 (en) 2001-08-01 2003-02-13 Medlogic Global Limited Cyanoacrylate monomer-containing antibiotic formulation for topical use
US20030100034A1 (en) 2001-10-16 2003-05-29 Millennium Pharmaceuticals, Inc. 9136, a human aldehyde dehydrogenase family member and uses therefor
DE10158712A1 (de) 2001-11-29 2003-06-26 Umwelttechnik Georg Fritzmeier Zusammensetzung zur Behandlung der Hautoberfläche
KR100536522B1 (ko) * 2003-03-07 2005-12-14 (주)바이오솔루션 인간 피부 유래의 신규한 박테리오신 및 여드름치료제로서의 용도
EP1786445B1 (en) * 2004-08-25 2011-06-08 The Government of the United States of America as represented by The Secretary of the Department of Health and Human Services Live microbial microbicides
JP2006131622A (ja) 2004-10-05 2006-05-25 Genichiro Soma 薬剤
KR20070091613A (ko) 2004-11-08 2007-09-11 그렌마크 파머수티칼스 엘티디. 항여드름 화합물 및 항생제 화합물을 함유하는 국소적 제약조성물
EP1736537A1 (en) 2005-06-22 2006-12-27 OrganoBalance GmbH Methods and means for protecting the skin against pathogenic microorganisms
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
JP6159084B2 (ja) 2009-06-30 2017-07-05 デルマン バイオメディシン カンパニー リミテッド 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物
US9050319B2 (en) 2010-04-30 2015-06-09 Telormedix, Sa Phospholipid drug analogs
WO2012150269A1 (en) 2011-05-03 2012-11-08 Dupont Nutrition Biosciences Aps Probiotic bacteria for the topical treatment of skin disorders
US20130121968A1 (en) 2011-10-03 2013-05-16 Atossa Genetics, Inc. Methods of combining metagenome and the metatranscriptome in multiplex profiles
WO2013130773A2 (en) 2012-02-29 2013-09-06 Ethicon Endo-Surgery, Inc. Compositions of microbiota and methods related thereto
GB201206599D0 (en) 2012-04-13 2012-05-30 Univ Manchester Probiotic bacteria
WO2014112196A1 (ja) 2013-01-15 2014-07-24 日本精工株式会社 チルト式ステアリング装置
EP3082431A4 (en) * 2013-12-16 2017-11-15 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
KR20230165365A (ko) 2014-04-15 2023-12-05 에이오바이오미 엘엘씨 암모니아-산화 니트로소모나스 유트로파 균주 d23
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
US9526201B2 (en) 2015-01-05 2016-12-27 Cnh Industrial America Llc Twin-row planter with tandem driven seed meters
CA3021690A1 (en) 2015-04-20 2016-10-27 S-Biomedic Nv Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
EP3445330B1 (en) 2016-04-19 2022-07-06 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of gram negative species to treat atopic dermatitis
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
US10695386B2 (en) 2017-05-11 2020-06-30 Shayne K. Morris Skin microbiome colonizer formulations and methods for use
BR112020021274A2 (pt) 2018-04-18 2021-04-13 Forte Subsidiary, Inc. Composições para o tratamento de doenças da pele
KR20210013080A (ko) 2018-05-11 2021-02-03 포르테 서브시디어리, 인크. 피부 병태의 치료를 위한 조성물
EA202190171A1 (ru) 2018-07-23 2021-06-24 Зэ Юнайтед Стэйтс Оф Америка, Эс Репрезентид Бай Зэ Секретри, Департмент Оф Хэлс Энд Хьюман Сервисез Применение грамотрицательных видов для лечения атопического дерматита

Similar Documents

Publication Publication Date Title
JP2019513769A5 (cg-RX-API-DMAC7.html)
BR112018001811A2 (pt) composição de bactérias láticas para uso no tratamento de infecções devidas a pro-pionibacterium acnes e em particular para acne
CA3006294A1 (en) Combinations of rapamycin and metformin for the treatment of joint and skin diseases
WO2015066647A3 (en) Ionic liquids for transdermal drug delivery
JP6429131B2 (ja) 膣症を予防および治療するために塩および糖を有効成分として含む皮膚外用組成物およびその使用
JP2016507532A5 (cg-RX-API-DMAC7.html)
PH12020500543A1 (en) Nonracemic mixtures and uses thereof
RU2014142038A (ru) Короткие антимикробные липопептиды
MX2022001736A (es) Formulaciones y tratamientos topicos.
GB2593281A (en) Use of gram negative species to treat atopic dermatitis
TR201904382T4 (tr) Vajinit tedavisi.
WO2016063265A3 (pt) Formulação tópica para o tratamento de infeções na pele ou mucosas, método de preparação e seus usos
JP2015522040A5 (cg-RX-API-DMAC7.html)
CN102824337A (zh) 一种治疗家畜子宫内膜炎的凝胶剂及其制备方法
JPWO2019002421A5 (cg-RX-API-DMAC7.html)
CN103948607A (zh) 杀菌抑菌冻疮膏
Yadav et al. Management of Burn in Bovines-A Clinical Study.
Fanting et al. Pharmacodynamic study of different formulations of gynecological ice snake
RU2020102673A (ru) Антибактериальная активность галактоолигосахарида и ксилита в дерматологических лечениях
Kashcheyeva et al. Prospects for the use of bacteriophages in cosmetology for the prevention of skin diseases
Verkhovodova In vitro study of antimicrobal activity of some salvia officinalis extracts
CN106728021A (zh) 一种金疮药
Schneider et al. Infectious Disease
Starzhinskaya et al. Improvement of extemporaneous ointment with wound healing action
CN104604960A (zh) 一种复方辣椒碱消毒剂